MD06: Coated dental implants

Description

MD06 is a titanium implant activated with rhGDF-5 for use in critical implantation sites. The titanium implant thus acquires osteoinductive properties making it especially useful for application in patients with poor bone quality.

The product will also offer aesthetic benefits, as the expected regenerative effect on the soft tissue should result in a natural gum appearance as well as a close connection of the soft tissue with the dental implant.

Using a proprietary protein coating technology for dental implant surfaces, the implant surface is loaded homogeneously with the growth factor, maintaining its molecular structure and biological activity. This formulation allows for a controlled release of the growth factor for up to 30 days as demonstrated by in vivo experiments.

Developmental stage

MD06 is currently in preclinical stage.

Intellectual property

A patent portfolio on the growth factor rhGDF-5 was licensed from Biopharm GmbH, Heidelberg, Germany, providing Scil with the global, exclusive rights for dentistry and maxillofacial surgery.